Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2025-02-08 2025-02-07
Drug Identification Number 02291924 02291924
Brand name BICILLIN L-A BICILLIN L-A
Common or Proper name BICILLIN L-A BICILLIN L-A
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients PENICILLIN G BENZATHINE PENICILLIN G BENZATHINE
Strength(s) 1200000UNIT 1200000UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 10 X 2ML 10 X 2ML
ATC code J01CE J01CE
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2025-01-31 2025-01-31
Actual start date
Estimated end date
Actual end date 2025-02-07 2025-02-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments